Achieve Life Sciences Depreciation & Amortization 2011-2026 | ACHV

Annual Depreciation & Amortization Achieve Life Sciences

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
228 K	229 K	228 K	236 K	250 K	255 K	31 K	60 K	59 K	188 K	244 K	223 K	227 K	100 K	75 K

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
255 K	31 K	176 K

Quarterly Depreciation & Amortization Achieve Life Sciences

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
100 K	100 K	62 K	-	100 K	100 K	57 K	-	100 K	100 K	58 K	-	100 K	100 K	60 K	-	188 K	127 K	64 K	-	191 K	126 K	61 K	-	192 K	130 K	65 K	-	220 K	154 K	86 K	-	191 K	111 K	56 K	-	166 K	103 K	56 K	-	178 K	116 K	46 K	-	165 K	110 K	55 K	-	162 K	100 K	44 K	-	71 K	43 K	19 K	-	56 K	37 K	19 K

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
220 K	19 K	101 K

Depreciation & Amortization of other stocks in the Biotechnology industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
Aytu BioScience AYTU	5.38 M	$ 2.66	-	$ 16.7 M	USA
I-Mab IMAB	23.9 M	-	-	$ 866 M	China
Cerus Corporation CERS	1.43 M	$ 1.85	-	$ 353 M	USA
Acorda Therapeutics ACOR	31.7 M	-	-24.86 %	$ 820 K	USA
Coherus BioSciences CHRS	1.3 M	$ 1.67	-	$ 196 M	USA
Celldex Therapeutics CLDX	3.38 M	$ 31.37	-	$ 2.08 B	USA
CollPlant Biotechnologies Ltd. CLGN	1.04 M	$ 0.44	-	$ 5.04 M	Israel
Advaxis ADXS	369 K	-	-9.65 %	$ 45.9 M	USA
Adverum Biotechnologies ADVM	3.65 M	-	-	$ 86.2 M	USA
CNS Pharmaceuticals CNSP	3.92 K	$ 2.32	-	$ 1.03 M	USA
Catalyst Pharmaceuticals CPRX	375 K	$ 24.98	-	$ 3.05 B	USA
Corbus Pharmaceuticals Holdings CRBP	233 K	$ 10.14	-	$ 135 M	USA
Cardiff Oncology CRDF	364 K	$ 1.58	-	$ 106 M	USA
Curis CRIS	169 K	$ 0.53	-	$ 6.98 M	USA
Crinetics Pharmaceuticals CRNX	3.9 M	$ 37.7	-	$ 3.55 B	USA
CRISPR Therapeutics AG CRSP	19.5 M	$ 49.15	-	$ 4.42 B	Schweiz
Aeterna Zentaris AEZS	58 K	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	100 K	-	-10.17 %	$ 12.2 K	USA
CytomX Therapeutics CTMX	1.2 M	$ 4.4	-	$ 607 M	USA
Citius Pharmaceuticals CTXR	1.43 K	$ 0.86	-	$ 5.79 M	USA
Aeglea BioTherapeutics AGLE	744 K	-	-	$ 1.01 B	USA
Cue Biopharma CUE	958 K	$ 0.18	-	$ 17.1 M	USA
Applied Genetic Technologies Corporation AGTC	1.51 M	-	-	$ 26.5 M	USA
DBV Technologies S.A. DBVT	2.99 M	$ 20.36	-	$ 2.84 B	France
AIkido Pharma AIKI	105 K	-	1.93 %	$ 17.4 M	USA
Aptose Biosciences APTO	22 K	-	-45.71 %	$ 1.2 M	Canada
Denali Therapeutics DNLI	7.8 M	$ 19.38	-	$ 3.19 B	USA
Akero Therapeutics AKRO	18 K	-	-	$ 3.67 B	USA
Akari Therapeutics, Plc AKTX	14 K	$ 3.54	-	$ 238 B	Britain
Akouos AKUS	2.49 M	-	0.23 %	$ 488 M	USA
Equillium EQ	116 K	$ 2.01	-	$ 115 M	USA
Allakos ALLK	6.14 M	-	-	$ 28.6 M	USA
Allena Pharmaceuticals ALNA	363 K	-	3.16 %	$ 1.9 M	USA
Alnylam Pharmaceuticals ALNY	55.7 M	$ 330.34	-	$ 43.3 B	USA
Alpine Immune Sciences ALPN	597 K	-	-	$ 2.17 B	USA
Fate Therapeutics FATE	12.9 M	$ 1.19	-	$ 141 M	USA
Aileron Therapeutics ALRN	1 K	-	10.36 %	$ 9.8 M	USA